Within the trimeric HIV-1 envelope (Env) spike, the first and second variable loops (V1V2 region) and the third variable loop (V3) of the gp120 subunit play dual roles in antibody recognition, because they contain neutralization epitopes and also participate in epitope masking. The spatial relationships between V1V2 and V3 and the associated mechanisms of epitope masking remain unclear. Here we investigated interactions between these domains using two monoclonal antibodies recognizing distinct conserved linear epitopes that are subject to masking in the functional trimer, which limits their neutralizing activities. Using Env pseudotype virus infection assays, we found that deleting the V1V2 region greatly enhanced neutralization by both antibodies, leading us to consider two alternative models: V1V2 on one gp120 protomer masks V3 on the same protomer (intraprotomer or cis masking) versus on an adjacent protomer (interprotomer or trans masking). Our experimental approach exploited a previously described complementation system wherein two variant Envs harboring different inactivating mutations (one in gp120, the other in gp41) are coexpressed in the same cell; functional Env results only from cooperative interactions within mixed trimers, thereby enabling selective examination of mixed trimer activity. We introduced additional mutations that either promoted (V1V2 deletion, i.e., unmasking) or prevented (GPGR to GPGQ mutation, i.e., epitope destruction) interaction with the antibodies. The observed neutralization sensitivities of mixed trimers produced from various combinations of constructs support the intraprotomer (cis) model of V1V2 masking of V3 epitopes.
Within the trimeric HIV-1 envelope (Env) spike, the first and second variable loops (V1V2 region) and the third variable loop (V3) of the gp120 subunit play dual roles in antibody recognition, because they contain neutralization epitopes and also participate in epitope masking. The spatial relationships between V1V2 and V3 and the associated mechanisms of epitope masking remain unclear. Here we investigated interactions between these domains using two monoclonal antibodies recognizing distinct conserved linear epitopes that are subject to masking in the functional trimer, which limits their neutralizing activities. Using Env pseudotype virus infection assays, we found that deleting the V1V2 region greatly enhanced neutralization by both antibodies, leading us to consider two alternative models: V1V2 on one gp120 protomer masks V3 on the same protomer (intraprotomer or cis masking) versus on an adjacent protomer (interprotomer or trans masking). Our experimental approach exploited a previously described complementation system wherein two variant Envs harboring different inactivating mutations (one in gp120, the other in gp41) are coexpressed in the same cell; functional Env results only from cooperative interactions within mixed trimers, thereby enabling selective examination of mixed trimer activity. We introduced additional mutations that either promoted (V1V2 deletion, i.e., unmasking) or prevented (GPGR to GPGQ mutation, i.e., epitope destruction) interaction with the antibodies. The observed neutralization sensitivities of mixed trimers produced from various combinations of constructs support the intraprotomer (cis) model of V1V2 masking of V3 epitopes.
envelope glycoprotein trimer | functional complementation | Env trimer structure | cis versus trans T he envelope glycoprotein (Env) of HIV-1 and the related simian immunodeficiency virus (SIV) is the molecular machine that drives virion entry into the target cell (1) . The Env spikes displayed on the surface of virions and infected cells are homotrimers of gp120/gp41 heterodimers, derived by proteolytic maturation of the gp160 precursor. Upon initiation of HIV-1 infection, gp120 binds first to the "primary" cellular receptor CD4, then to the "coreceptor," i.e., chemokine receptor CCR5 or CXCR4. These sequential events are associated with dramatic conformational changes in both the gp120 and gp41 subunits, leading to insertion of the N-terminal fusion peptide of gp41 into the membrane of the target cell, followed by gp41 refolding and direct fusion of the virion and plasma membranes. The end result is virion entry. Because of its role in the initial step of HIV infection and its prominent display on the virion surface, the Env spike is the primary target of neutralizing antibodies during natural infection and for vaccine development (2) . Moreover, the preferential reactivity of an Env for CCR5 and/or CXCR4 dictates the tropism of HIV-1 variants for different CD4-expressing target cell types, a critical determinant of HIV transmission and pathogenesis (3) . Entry inhibition has become a major focus in the ever-expanding array of strategies to prevent and treat HIV infection (4) .
The oligomeric structure of Env is not only required for its fusogenic function, but also provides an important mode to protect conserved epitopes against humoral immune surveillance. The lack of correlation between the neutralizing capacity of an antibody and its ability to bind to monomeric gp120 has long been recognized, with antibody binding to the functional trimer being a critical requirement for neutralization (5) . The variable domains displayed on the surface of gp120 have been a major focus in the study of Env immunogenicity and antibody evasion, particularly the first and second variable loops (V1V2 region) and the third variable loop (V3). These domains display duality with respect to antibody recognition. On the one hand, they contain epitopes that are targeted by neutralizing antibodies (strain-specific as well as broadly reactive); indeed, the potential for the variable regions, particularly V3, to serve as vaccine targets remains an active focus of research and debate (6) (7) (8) . On the other hand, these domains provide an epitope-shielding function whereby V1V2 conceals many (9-12), although not all (13), V3 epitopes from antibody binding.
Despite extensive molecular and structural studies, the relative spatial arrangements of the V1V2 and V3 regions in the functional trimer remain unclear. A central question regarding epitope masking is whether the V1V2 region on one protomer exerts its shielding effect on V3 of the same protomer (intraprotomer; hereafter designated as "cis" masking) or of a neighboring protomer (interprotomer; hereafter designated as "trans" masking).
In the present report we analyze this question by focusing on neutralization of Env pseudotype viruses by two monoclonal antibodies (mAbs) recognizing distinct conserved V3 epitopes masked by V1V2. We devised a functional strategy based on a previously described Env complementation system (14, 15) to distinguish between cis versus trans mechanisms of epitope masking. The results are discussed in terms of various proposed trimer models based on structural analyses and molecular modeling.
Results
Choice of V3 mAbs Based on Epitope Masking by V1V2. In the present studies, Env complementation activities were analyzed by a single round Env pseudotype virus infectivity assay involving the packaged firefly luciferase reporter gene; this system is widely used for studying HIV entry and neutralization (16, 17) , including analyses of anti-V3 mAbs and epitope masking by V1V2 To whom correspondence should be addressed. E-mail: edward_berger@nih.gov.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. 1073/pnas.1104840108/-/DCSupplemental. (12, 18) . Flow cytometry of transfected 293T cells analyzing both gp120 and gp41 showed comparable cell surface expression levels of all of the Env variants (derived from the Ba-L strain) used in this study (Fig. S1) .
We chose two mAbs that recognize distinct conserved V3 epitopes present on numerous isolates from multiple HIV-1 genotypes, which are subject to epitope masking in the Env trimer. Human mAb 2182, derived from an individual infected with HIV-1 clade A, binds to a 35-mer V3 loop peptide and competes with mAb 447-52D (18), a well-characterized human mAb that recognizes the V3 tip (19) . Pseudotype studies with chimeric Env constructs implicated a critical role of V1V2 in masking the 2182 epitope (12) . Murine mAb D19, generated by immunization with a clade B gp140 construct (20) , binds to a linear peptide derived from the tip of the V3 loop; this epitope is relatively conserved (particularly in clade B strains) and is overlapping but distinct from that of 447-52D (21) . Particularly intriguing was the observation that among different isolates, there was a strong correlation between coreceptor use phenotype and D19 epitope accessibility in the functional Env trimer (21) . In R5 strains, the epitope is invariably cryptic in the trimer and becomes accessible only upon CD4 binding; thus, R5 strains are resistant to D19 neutralization despite the presence of the epitope. By contrast, the epitope is accessible on R5 monomeric gp120 in the absence or presence of soluble CD4 (sCD4), suggesting that structural features of the trimer are responsible for D19 epitope masking in the Env spike. The situation differs for CXCR4-using Envs (R5X4 and X4), in which the D19 epitope is exposed on the functional trimer independent of CD4 binding; consequently, such strains are sensitive to D19 neutralization.
Based on the above reports indicating a major role for V1V2 in masking V3 loop epitopes, we examined the effects of deleting this region on neutralization sensitivity to these anti-V3 mAbs, using the pseudotype assay with the R5 Ba-L Env. Fig. S2A demonstrates that deletion of the V1V2 region dramatically enhanced the neutralization sensitivity to mAb 2182, consistent with previously described effects in pseudotype assays comparing chimeric Envs containing the same V3 loop and the V1V2 domain of strains either highly resistant or highly sensitive to neutralization by anti-V3 antibodies (12) . We applied the same test to mAb D19 (Fig. S2B ). Consistent with our previous findings based on spreading infection assays (21), we observed that pseudotype virus expressing the R5 Ba-L Env was resistant to neutralization by mAb D19; deletion of V1V2 conferred D19 sensitivity. In five experiments, the level of D19 inhibition plateaued between 63% and 80% (mean 68% ± 8%), suggesting that additional components in the trimer besides V1V2 contribute to D19 epitope masking. Incomplete unexplained plateaus of HIV-1 neutralization have been reported for several antibodies in various assay systems (e.g., ref.
22).
Mutational Destruction of the 2182 and D19 Epitopes. The consensus sequence motif at the V3 tip in primary clade B Envs is GPGR, the consensus in Envs from clades A and C is GPGQ (7). It has been reported (12, 23 ) that mutation of GPGR to GPGQ [here designated R18Q, based on numbering of the V3 loop clade B consensus sequence (7)] destroys the epitopes for several anti-V3 mAbs including 2182 while maintaining Env function. Our previous peptide mapping studies indicated that the GPGR motif at the tip of V3 is critical for D19 binding (21) . To test whether the R18Q mutation affects the D19 epitope, we used the sCD4-activated variation of the cell fusion assay wherein Env-expressing cells are induced by sCD4 to fuse with cells expressing coreceptor but not CD4; this system is particularly suited for assessing mAb reactivity to CD4-inducible epitopes in the functional Env trimer (24) . Fig. S3 shows that wild-type Ba-L Env-mediated fusion was strongly inhibited by mAb D19 in the sCD4-activated assay, consistent with previous findings (21); the R18Q mutation preserved the overall fusion activity but completely abolished mAb D19 sensitivity.
Demonstration of Env Complementation with HIV Virion Particles
Using the Env Pseudotype Infection System. Our previous analyses of subunit complementation (i.e., generation of functional mixed trimers upon coexpression of two Envs with different inactivating mutations) used the Env-mediated cell fusion assay (14, 15) , which is highly sensitive for detecting Env function. Here we wished to apply the Env pseudotype virion infection system to test for complementation with virus particles. In the experiment shown in Fig. S4 , one Ba-L construct contained the D368R substitution in gp120 that inactivates the CD4 binding site (herein designated BS); another Ba-L construct contained the L26R substitution in gp41 that inactivates the fusion peptide (herein designated FP). Fig. S4A shows that complementation was readily detectable with the pseudotype assay, although the efficiency of the mixed trimers was ∼100-fold less than that observed with wild-type constructs based on the 50% tissue culture infectious dose (TCID 50 ). This lower efficiency presumably accounts for our previous lack of detection of mixed trimer complementation by virions using the less sensitive multinuclear-activation galactosidase indicator (MAGI) infectivity assay (15) . Fig. S4B shows that the luciferase activity resulting from complementation was readily detectable over background and displayed dose dependence of signal with pseudovirus input over the range tested. Thus, the pseudotype system appeared suitable to apply the complementation approach to study epitope masking in the functional trimer.
Experimental System to Assess Cis Versus Trans Epitope Masking.
With the knowledge that the V1V2 region is involved in masking of the D19 epitope on the V3 loop within the functional Env trimer, we sought to distinguish whether masking occurs via a cis versus trans mechanism, i.e., V1V2 masking of V3 on the same versus adjacent protomers, respectively. This question could be studied with the Env complementation system by introducing on separate constructs, in addition to the fusion-impairing BS and FP defects, the two specific modifications designed to address the epitope masking mechanism, namely, deletion of the V1V2 loop (ΔV1V2) and mutation of the D19 epitope (R18Q). As illustrated schematically in Fig. 1 , different sensitivities to 2182 and D19 neutralization would be predicted for cis versus trans masking mechanisms in experimental designs wherein these modifications were introduced on the same (Fig. 1A) versus different (Fig. 1B ) Env constructs. In considering interpretation of possible experimental outcomes, it is critical to note previous conclusions that antibody binding to a single subunit within an HIV-1 trimer is sufficient to neutralize its function, based on experimental data coupled with computational modeling (25) (26) (27) (28) . This conclusion has been reached in studies by multiple research groups with a variety of mAbs against diverse determinants on both gp120 (CD4 binding site, CD4-induced epitopes, oligomannose determinants) and gp41 (membrane proximal external region) and against multiple HIV-1 isolates.
Analysis of Mixed Trimers in Which the ΔV1V2 Deletion and the R18Q
Mutation Are Present on the Same Protomer. In one experimental variation (Fig. 1A) , we generated the following two defective Ba-L Env constructs: BS-ΔV1V2_Q (designated "a") and FP (designated "b"). The former construct contained not only the BS inactivating mutation, but also deletion of the V1V2 region and the 2182/D19 epitope-destroying mutation; the latter construct contained only the FP inactivating mutation. According to the scheme shown in Fig. 1A , pseudotypes formed from this pair of Envs were predicted to yield readily interpretable mechanistic results: Cis epitope masking would result in 2182 and D19 neutralization resistance, whereas trans masking should yield sensitivity to 2182 and D19 (in the latter case presumably comparable to the 63-80% inhibition noted above for ΔV1V2 homotrimers). The experimental results (Fig. 2, filled symbols) demonstrated no neutralization by either 2182 (Left) or D19 (Right) over a broad concentration range, suggestive of a cis epitope masking mechanism.
Analysis of Mixed Trimers in Which the ΔV1V2 Deletion and the R18Q Mutation Are Present on Different Protomers. In a second experimental variation (Fig. 1B) , we examined complementation between two different defective Ba-L Env constructs: BS-ΔV1V2 (designated "c") and FP-Q (designated "d"). According to the scheme shown in Fig. 1B , the anticipated results would give a suggestive, although not unequivocal interpretation: Cis masking would result in 2182 and D19 sensitivity, whereas a trans mechanism would yield partial/conditional resistance, because one heterotrimer type (two c, one d) would be sensitive, whereas the other (one c, two d) would be resistant. As shown in Fig. 2 (open symbols), mAb 2182 (Left) inhibited pseudovirus infection with a dose-response curve similar to that observed for ΔV1V2 homotrimers (Fig. S2A) . Likewise, mAb D19 (Fig. 2 Right) blocked infection mediated by this pair of mixed trimers, with inhibition leveling at ∼65% (ranging from 50% to 65% in multiple experiments); this pattern closely resembled that observed with ΔV1V2 homotrimers (Fig. S2B) .
Although this experimental variation does not unambiguously distinguish between cis versus trans masking mechanisms, additional insights could be gained by varying the ratios of the two Env constructs. According to a trans mechanism, transfection with an excess of BS-ΔV1V2 over FP-Q (excess c over d in Fig.  1B) would be expected to result in expression of a greater proportion of neutralization-sensitive heterotrimers compared with transfection with equivalent amounts of the two constructs, resulting in greater sensitivity to 2182 and D19 neutralization; transfection with excess FP-Q over BS-ΔV1V2 (excess d over c in Fig. 1B) would be predicted to display the opposite trend, i.e., reduced sensitivity to the mAbs. A cis mechanism would be expected to yield comparable neutralization sensitivities, independent of the ratios of the two constructs. Fig. 3A shows indistinguishable neutralization curves for D19 over a ninefold variation in the transfection ratios of the two Env constructs, consistent with a cis masking mechanism. To confirm the reliability of this interpretation, we analyzed the relative amounts of the two Env protein variants in the isolated pseudovirions, readily distinguishable by size based on the presence or absence of the V1V2 region. The immunoblot in Fig. 3A shows that, although the relative amount of d compared with c protein in the pseudovirions increased in keeping the variation in transfection ratio, the d construct was relatively underexpressed. This result prompted us to assess the effects of transfecting the d construct at much greater excess compared with the c construct, in an effort to drive the production of pseudovirions predicted by the trans mechanism to be less sensitive to neutralization. Fig. 3B shows that for both D19 and 2182, indistinguishable neutralization sensitivities were observed over a range of transfection ratios involving a large excess of d compared with c (up to 19:1); the corresponding immunoblot of isolated pseudovirions verifies relative overabundance of the d protein compared with c at the highest transfection ratio. Table S1 summarizes the relative amounts of the two protein variants over a wide range of transfection ratios; the d:c protein ratios in the isolated pseudovirions varied over a nearly a 10-fold range, from a relatively minor species (0.25:1) to an overabundant component (2.4:1). Together, the data in Fig. 3 and Table S1 demonstrate no effect on 2182 or D19 neutralization sensitivities of driving the protein composition of the pseudovirions in a direction predicted by the trans mechanism to promote neutralization resistance. These results provide further support for the cis model of V1V2 masking of V3 epitopes in the Env trimer.
Mixed Trimer Neutralization Patterns for Non-V3 mAbs. To further validate the interpretation of cis masking of the V3 epitopes, we analyzed mAbs against distinct Env determinants that are not subject to V1V2 masking and hence should not display the same patterns of mixed trimer neutralization observed for the anti-V3 mAbs. The mAbs analyzed included 2G12, which recognizes a high mannose determinant on gp120, IgG1 b12 targeting the CD4 binding site, and 2F5 and 4E10 directed against the membrane proximal external region of gp41. The data in Fig. 4 show that, unlike 2182 and D19, which displayed dramatically different activities against mixed trimers composed of constructs a + b (minimal neutralization) compared with c + d (effective neutralization) (Fig. 2) , the other mAbs showed comparable activities against these different mixed trimers. Thus, we conclude that the patterns of 2182 and D19 neutralization described above indeed reflected the mechanism of V3 masking by V1V2 rather than generalized variations in neutralization sensitivity of the different mixed trimers due to global conformational alterations accompanying deletion of V1V2.
Discussion
The data reported herein support a cis mechanism for V3 loop epitope masking by the V1V2 region of gp120 within the functional HIV-1 Env trimer. A simple explanation is that the flexibility of gp120 is greatly constrained in the trimer compared with the monomer, such that (a portion of) the V3 loop, including the 2182 and D19 epitopes, is held predominantly in a cryptic position. The V1V2 region could contribute to this constraint, given the recent interpretation that V1V2 deletion results in increased subunit flexibility within the trimer (29) . Although our use of the term "masking" implies that the 2182 and D19 epitopes exist in the trimer but are directly shielded by steric interference of V1V2, alternative indirect mechanisms are possible. For example, the presence of V1V2 might enable another region of Env to shield V3, or V1V2 might prevent the V3 loop from adopting the conformation required for 2182 and D19 binding. Regarding the latter point, the ability of V3-based peptides to adopt alternative conformations when bound to different antibodies has been known for some time (30) . In any case, our data indicate that the influence of V1V2 on accessibility of the 2182 and D19 epitopes on V3 is manifested within the same protomer, rather than between adjacent protomers in the trimer.
Our experimental approach using analysis of V3 mAb neutralization sensitivity of coexpressed mutant Envs had the advantage of probing only the subset of surface Env molecules capable of giving a functional signal, i.e., the mixed trimers. An alternative approach of measuring mAb binding to Env-expressing cells could potentially be complicated not only by the presence of inactive homotrimers of each mutant construct, but also by other nonfunctional forms of Env that are likely expressed on the transfected cells. These include trimers of uncleaved gp160 as well as gp120/gp41 monomers, which have been reported on virus-like particles and infectious virions (31) (32) (33) and found to display different patterns of epitope exposure compared with the correctly processed functional trimers (34) (35) (36) .
The present demonstration of cis masking of V3 epitopes by the V1V2 region can be considered in terms of previous analyses combining structural data with molecular modeling. Extensive Xray crystallographic analyses of constructs based on the individual HIV-1 (and SIV) gp120 and gp41 subunits, and their interactions with specific receptors and specific mAbs, have contributed detailed atomic-level insights into the mechanisms of virus entry and antibody-mediated neutralization (reviewed in refs. 1, 8, and 37) . Although the Env trimer has not yet proven amenable to X-ray crystallography, recent cryoelectron tomography studies have yielded ultrastructural images of the native Env trimers in unliganded, CD4-bound, and antibody-bound forms (29, (38) (39) (40) (41) (42) (43) (44) . Differences in the reconstructed images and in the fitting of X-ray crystallographic structures of monomeric forms of gp120 into trimer models have led to evolving interpretations. For example, early models of the unliganded SIV Env trimer depicted the V1V2 stem as pointing toward the base of the trimer (38, 39, 45) , whereas subsequent analyses of HIV-1 Env suggested this region points toward the trimer apex (29, (42) (43) (44) . Various factors that might contribute to these different models have been suggested, including potential inherent differences between SIV and HIV Envs (42, 43) and the possibility that the gp120 conformations captured in the crystals might not represent the structures present in the native trimers (42) . With respect to the central question addressed in the present report, several modeling studies have suggested that the V1V2 region resides proximal to V3 on neighboring protomers in unliganded (29, 43, 45) and CD4-bound (46) trimers; such models would be supportive of a trans epitope masking mechanism. However, in other cryoelectron tomography models of the trimer (42, 44) , the stumps of the V1V2 loop are much closer to the stumps of the V3 loop from the same protomer, consistent with cis rather than trans protomer interactions. In attempting to rationalize these differing conclusions, we point out the caution that has been noted regarding efforts to fit liganded atomic structures into unliganded cryoelectron tomographic densities, particularly in view of the dynamic structural changes associated with CD4 binding to gp120 (29) . Our data suggesting cis masking are consistent with recent binding studies suggesting that the quaternary epitopes for mAbs PG9 and PG16 are composed of determinants on V2 and V3 within the same gp120 subunit (22) . It would be interesting to apply our approach based on neutralization of complementing mixed trimers to these and other reported V2/V3-dependent quaternary epitopes (47, 48) .
Materials and Methods
General. See SI Materials and Methods for descriptions of cells and culture conditions, purification of antibodies and proteins, construction and nomenclature of plasmids, fluorocytometric analysis of surface expression of Env variants, the cell fusion assay, and biochemical analysis of Env glycoproteins in pseudovirus particles. The names and properties of plasmid constructs are described in Table S2 .
Pseudovirus Preparation. HIV-1 pseudoviruses were prepared as described (49) in 800 μL of Opti-MEM (Invitrogen). The cells were incubated overnight at 37°C in 5% CO 2 , after which the medium was removed and replaced with 11 mL of fresh DMEM-10%. At 48 h posttransfection, the supernatants were harvested and centrifuged at 1,400 × g for 15 min. Cleared supernatants containing pseudoviruses were filtered through a 0.45-μM filter (Millipore) and then divided into 1-mL aliquots, frozen on dry ice, and stored at −80°C.
Pseudovirus Infectivity and Neutralization Assays. Pseudovirus infectivity was quantitated in a single-round assay measuring firefly luciferase activity in cell lysates (50) . To titer pseudovirus preparations, serial fivefold dilutions (5 −1 to 5
) of pseudovirus were prepared in quadruplicate in a 96-well plate. SupT1-DCSIGNR target cells (2 × 10 5 ) were added to each of the wells. For mockinfected negative control, the viral inoculum was replaced by DMEM. The final volume of cell-virus mixture was 200 μL containing 20 μg/mL DEAE-dextran. After 2-d culture at 37°C, 100 μL of culture supernatants was removed, and 100 μL of BrightGlo reagent (Promega) was added to the cells. After 2-min incubation at room temperature to allow cell lysis, 150 μL of cell lysates was transferred to 96-well white solid plates for measurements of luminescence by using a SynergyMx luminometer (Biotek). The cutoff value was set as three times of the average of the negative control readings. Wells with readings greater than the cutoff value were scored as positive. Subsequently, virus titer was determined by calculating TCID 50 per milliliter using the Reed-Muench method.
The effects of neutralizing antibodies were measured as reductions in luciferase activity after a single round of virus infection in SupT1-DCSIGNR cells by using a described method (49) . Briefly, appropriate dilutions of the pseudovirus-containing culture supernatants were incubated with various dilutions of test antibodies in duplicate for 30 min at 37°C in 96-well flatbottom culture plates (Corning-Costar). 2 × 10 5 cells in growth medium were added to each well. One pair of positive control wells received cells plus virus (no antibody control), and another pair of wells received cells only (background control). After 48-h incubation in the presence of 20 μg/mL DEAEdextran, 100 μL of culture medium was removed from each well, and 100 μL of BrightGlo reagent (Promega) was added to the cells. After 2-min incubation at room temperature to allow cell lysis, 150 μL of cell lysates was transferred to 96-well white solid plates for measurements of luminescence by using a SynergyMx luminometer (Biotek). The infectivity was determined by comparing the relative light units in the presence and absence of mAbs and expressed as a percentage of virus control (no antibody). Note. During the review of this manuscript, a report was published reaching a different conclusion, i.e., that the V1V2 loop shields V3 epitopes on a neighboring gp120 subunit within the HIV-1 trimer (51) . As in the present study, the experimental approach involved coexpression of different combinations of Env variants deleted for V1V2 and/or incapable of anti-V3 mAb binding. The analysis used a mathematical 
